160 related articles for article (PubMed ID: 35938037)
1. Comprehensive Analysis of
Gao Y; Li JY; Mao JY; Zhou JF; Jiang L; Li XP
Front Genet; 2022; 13():923568. PubMed ID: 35938037
[TBL] [Abstract][Full Text] [Related]
2. Methylation-independent
Ma BB; Zhang TJ; Wang CZ; Xu ZJ; Zhou JD; Gu Y; Ma JC; Deng ZQ; Lin J; Qian J
Am J Transl Res; 2020; 12(9):4840-4852. PubMed ID: 33042393
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
Fu D; Zhang B; Wu S; Feng J; Jiang H
Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
[TBL] [Abstract][Full Text] [Related]
4. Integration of CD34
Li XP; Zhang WN; Mao JY; Zhao BT; Jiang L; Gao Y
J Transl Med; 2022 Aug; 20(1):359. PubMed ID: 35962395
[TBL] [Abstract][Full Text] [Related]
5. Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia.
Ye C; Ma S; Xia B; Zheng C
Med Sci Monit; 2019 Oct; 25():7396-7406. PubMed ID: 31577790
[TBL] [Abstract][Full Text] [Related]
6. CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway.
Deng X; Zeng Y; Qiu X; Zhong M; Xiong X; Luo M; Zhang J; Chen X
Leuk Res; 2023 Jul; 130():107312. PubMed ID: 37224580
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CD34
Li X; Dai Y; Chen B; Huang J; Chen S; Jiang L
Front Med; 2021 Aug; 15(4):608-620. PubMed ID: 33754282
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of
Qi B; Liu S; Liu D; Yao H; Yan R
Dis Markers; 2022; 2022():2687867. PubMed ID: 35140819
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls.
Song Y; Hao Q; Zhang G; Fang Q; Wang Z; Li Y; Wei H; Wang Y; Jiang E; Tian Z; Jia Y; Wang M; Wang J; Mi Y
Ann Transl Med; 2022 Jan; 10(2):82. PubMed ID: 35282130
[TBL] [Abstract][Full Text] [Related]
10. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
11. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Chen X; Zhao L; Yu T; Zeng J; Chen M
Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
13. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
15. The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia.
Su X; Ma G; Bai X; Zhang J; Li M; Zhang F; Sun T; Ma D; Lu F; Ji C
Front Cell Dev Biol; 2022; 10():978786. PubMed ID: 36313565
[TBL] [Abstract][Full Text] [Related]
16. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
Shi L; Huang R; Lai Y
BMC Med Genomics; 2021 May; 14(1):127. PubMed ID: 33985510
[TBL] [Abstract][Full Text] [Related]
18. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target.
Xu J; Dong X; Wang R; Chen B
Front Med (Lausanne); 2022; 9():842383. PubMed ID: 35321466
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Model for Acute Myeloid Leukemia Based on IL-2/STAT5 Pathway-Related Genes.
Tang Y; Xiao S; Wang Z; Liang Y; Xing Y; Wu J; Lu M
Front Oncol; 2022; 12():785899. PubMed ID: 35186733
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
Ha M; Han ME; Kim JY; Jeong DC; Oh SO; Kim YH
J Cell Biochem; 2019 Mar; 120(3):3672-3678. PubMed ID: 30203488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
